DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Kim JY, Min JY, Baek JM. et al.
CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Bone 2015;
79: 242-251
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.